blooducation's podcast: Recent Episodes
Blooducation
Haematology podcasts bringing the latest #blooducation to medical professionals. Supported by QEHB Charity
Suzy talks to Laura Green about the practical aspects of major haemorrhage and the evidence underpinning practice.
Links BSH Major Haemorrhage Guidelines
This week we discuss Hairy Cell Leukaemia and reclassifying Variant HCL with Dr Nilima Parry-Jones and Dr Anurag Joshi
Suzy speaks to Quentin Hill about pitfalls in diagnosis and treatment of haemolytic anaemia.
Helen talks to Suzy Morton about different blood components and when they are indicated
Links: NHSBT portfolio of blood components NHSBT guidelines on management of IgA deficiency
Suzy talks with the medical director of SHOT about the 2021 SHOT report and hot topics in haemovigilance
Thrombophilia testing can be confusing. Dr Will Lester speaks to Helen about when it’s useful… and when it’s not
Sickle cell anaemia is a common inherited disorder with many chronic complications as well as acute presentations. Finally there are some novel treatments on the horizon. Dr Shivan Pancham discusses current management with Suzy in part 2 of the podcast
Sickle cell anaemia is a common inherited disorder with many chronic complications as well as acute presentations. Finally there are some novel treatments on the horizon. Dr Shivan Pancham discusses current management with Suzy
Granulocytes in England are unusual as they are provided as a component pooled from whole blood. Helen and Suzy discuss when their use should be considered and what to watch out for when using them
Helen discusses current management of Essential Thrombocythaemia with Dr Hayder Hussein
PNH is a very rare disease but it is important for all haematologists to know when to test and what to do when a clone is detected. Suzy talks to Dr Morag Griffin about diagnosis and management.
It can be confusing to learn about different blood group systems. Tom Bullock, consultant clinical scientist at NHSBT, tells Suzy the characteristic features of each. Part 2 - other clinically relevant blood group systems.
It can be confusing to learn about different blood group systems. Tom Bullock, consultant clinical scientist at NHSBT, tells Suzy the characteristic features of each. Part 1 - fundamentals of antibody screening and the Rh blood group system.
Calls about reversal of anticoagulation are very common. But with DOACs now commonly used, what drugs are licensed and when should they be used? Helen talks to Dr Gill Lowe about the practical aspects of these issues.
Platelet aggregometry is a vital tool in diagnosis of patients thought to have a congenital platelet defect. But how is it done and what are the diagnostic features? Dr Gill Lowe talks Helen through this tricky topic.
We are just at the start of what many are calling “the CAR-T cell revolution”. But what are CAR-T cells, how are they made, who can receive them and what are the draw-backs? Dr Sridhar Chaganti talks to Suzy Morton about haematology’s latest breakthrough.
Everyone talks about patient blood management but what actually is it? Helen quizzes Dr Suzy Morton on the practical elements of patient blood management, including a run through a practical approach to iron deficiency.
Sara Wright, clinical scientist at NHSBT, talks Suzy through the different methods for obtaining and ABO and D group, the common discrepancies that arise and how to resolve them.
Dr Will Lester explains how best to approach the diagnosis and how management differs depending on the subtype
Dr Manoj Raghavan speaks to Suzy about the 2016 revised WHO classification of MDS and gives some hints about what is likely to be coming in the revised BSH guideline.
Listen to Helen talk to Dr Manos Nikolousis about the recent changes in the management of acute myeloid leukaemia
Blood support for ABO incompatible stem cell transplants can be tricky. Listen to Dr James Griffin as discusses the theory behind blood component support with Suzy and explains how to minimise the risks for patients having ABO incompatible transplants.
O D negative blood is in demand, and use will always run higher than the proportion of donors, but why is it so crucial to maintain the supply and how can we make sure we are using it wisely? Helen talks to Dr Suzy Morton about the issues.
Confused on when to give obinutuzumab or rituximab or which chemotherapy backbone to use in follicular lymphoma? Helen quizzes Dr Toby Eyre on what the options are and the evidence behind the current management of follicular lymphoma.
Struggling to understand the difference between adsorptions and elutions? Ruth Evans from NHS Blood and Transplant talks Suzy through investigating the patient with a panreactive antibody screen.
CLL is the commonest leukaemia in western society and management has changed dramatically over the past decade. Suzy talks to Dr Helen Parry about what new therapeutic options are available.